In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy.
CITATION STYLE
Sponaas, A. M., Waage, A., Vandsemb, E. N., Misund, K., Børset, M., Sundan, A., … Standal, T. (2021, February 15). Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango? Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2021.636375
Mendeley helps you to discover research relevant for your work.